EP2863890A4 - Fenofibrate formulation - Google Patents
Fenofibrate formulationInfo
- Publication number
- EP2863890A4 EP2863890A4 EP12880074.5A EP12880074A EP2863890A4 EP 2863890 A4 EP2863890 A4 EP 2863890A4 EP 12880074 A EP12880074 A EP 12880074A EP 2863890 A4 EP2863890 A4 EP 2863890A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- fenofibrate formulation
- fenofibrate
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 title 1
- 229960002297 fenofibrate Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2012/043971 WO2014003706A1 (en) | 2012-06-25 | 2012-06-25 | Fenofibrate formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2863890A1 EP2863890A1 (en) | 2015-04-29 |
EP2863890A4 true EP2863890A4 (en) | 2015-12-09 |
Family
ID=49783663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12880074.5A Pending EP2863890A4 (en) | 2012-06-25 | 2012-06-25 | Fenofibrate formulation |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2863890A4 (en) |
BR (1) | BR112014032579A2 (en) |
CA (1) | CA2877901A1 (en) |
IN (1) | IN2014DN11044A (en) |
WO (1) | WO2014003706A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101925590B1 (en) * | 2016-08-30 | 2018-12-05 | 대원제약 주식회사 | Formulation of fenofibric acid with improved bioavailability |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040137055A1 (en) * | 1999-07-09 | 2004-07-15 | Bruno Criere | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
WO2008014175A2 (en) * | 2006-07-28 | 2008-01-31 | Dr. Reddy's Laboratories Ltd. | Granular pharmaceutical compositions |
US20100166857A1 (en) * | 2008-12-30 | 2010-07-01 | Dong Yan | Pharmaceutical dosage forms and methods of manufacturing same |
US20110217369A1 (en) * | 2009-09-03 | 2011-09-08 | Ranbaxy Laboratories Limited | Fenofibrate compositions |
US20110311619A1 (en) * | 2008-12-24 | 2011-12-22 | Ethypharm | Pharmaceutical formulation of nanonised fenofibrate |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2627696B1 (en) | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | NEW GALENIC FORM OF FENOFIBRATE |
US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
US8586094B2 (en) * | 2000-09-20 | 2013-11-19 | Jagotec Ag | Coated tablets |
US20080241070A1 (en) * | 2000-09-21 | 2008-10-02 | Elan Pharma International Ltd. | Fenofibrate dosage forms |
RU2007133601A (en) * | 2005-02-10 | 2009-03-20 | Лайфсайкл Фарма А/С (Dk) | SUSTAINABLE PHARMACEUTICAL COMPOSITION CONTAINING A FIXED DOSE OF A COMBINATION OF Phenofibrate and an HMG-CoA reductase inhibitor |
-
2012
- 2012-06-25 EP EP12880074.5A patent/EP2863890A4/en active Pending
- 2012-06-25 IN IN11044DEN2014 patent/IN2014DN11044A/en unknown
- 2012-06-25 CA CA2877901A patent/CA2877901A1/en not_active Abandoned
- 2012-06-25 BR BR112014032579A patent/BR112014032579A2/en not_active Application Discontinuation
- 2012-06-25 WO PCT/US2012/043971 patent/WO2014003706A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040137055A1 (en) * | 1999-07-09 | 2004-07-15 | Bruno Criere | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
WO2008014175A2 (en) * | 2006-07-28 | 2008-01-31 | Dr. Reddy's Laboratories Ltd. | Granular pharmaceutical compositions |
US20110311619A1 (en) * | 2008-12-24 | 2011-12-22 | Ethypharm | Pharmaceutical formulation of nanonised fenofibrate |
US20100166857A1 (en) * | 2008-12-30 | 2010-07-01 | Dong Yan | Pharmaceutical dosage forms and methods of manufacturing same |
US20110217369A1 (en) * | 2009-09-03 | 2011-09-08 | Ranbaxy Laboratories Limited | Fenofibrate compositions |
Non-Patent Citations (1)
Title |
---|
See also references of WO2014003706A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2863890A1 (en) | 2015-04-29 |
WO2014003706A1 (en) | 2014-01-03 |
CA2877901A1 (en) | 2014-01-03 |
BR112014032579A2 (en) | 2017-06-27 |
IN2014DN11044A (en) | 2015-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1208372A1 (en) | Liquid formulation | |
PL3181128T3 (en) | Nilotinib pharmaceuticalcomposition | |
GB201111438D0 (en) | Formulation | |
HK1204973A1 (en) | Diclofenac formulations | |
ZA201309221B (en) | Formulation | |
GB201216800D0 (en) | Novel use | |
HK1202445A1 (en) | New formulation | |
EP2827074A4 (en) | Humidifier | |
HK1205146A1 (en) | Pharmaceutical formulation | |
ZA201306000B (en) | Stable formulation | |
HK1201270A1 (en) | Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides -5---5-- | |
EP2883547A4 (en) | Medicine | |
ZA201402456B (en) | Formulation | |
PL2908835T3 (en) | Stable formulations | |
EP2827073A4 (en) | Humidifier | |
GB201218012D0 (en) | Dosage forms | |
EP2822599A4 (en) | Vaccine formulation | |
GB201215502D0 (en) | Medical use | |
SG11201406097SA (en) | Capsule formulation | |
EP2863894A4 (en) | Fenofibrate formulation | |
EP2863890A4 (en) | Fenofibrate formulation | |
GB201106958D0 (en) | Formulation | |
GB201211247D0 (en) | Improved formulation | |
GB201206178D0 (en) | Formulations | |
GB201206393D0 (en) | Use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20150126 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20151111 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 9/50 20060101ALI20151105BHEP Ipc: A61K 9/48 20060101ALI20151105BHEP Ipc: A61K 9/16 20060101ALI20151105BHEP Ipc: A61K 9/14 20060101AFI20151105BHEP Ipc: A61P 3/06 20060101ALI20151105BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
R17P | Request for examination filed (corrected) |
Effective date: 20150126 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20180131 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0009140000 Ipc: A61K0009160000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 3/06 20060101ALI20240403BHEP Ipc: A61K 9/50 20060101ALI20240403BHEP Ipc: A61K 9/48 20060101ALI20240403BHEP Ipc: A61K 9/16 20060101AFI20240403BHEP |
|
INTG | Intention to grant announced |
Effective date: 20240425 |